Accumulation of amyloid-β (Aβ) peptides, generated from amyloid-β precursor protein (AβPP) amyloidogenic processing, is one of the most salient disease hallmarks of Alzheimer’s disease (AD). Nicotine is able to promote α-secretase-mediated AβPP nonamyloidogenic processing and increase the release of sAβPPα and C-terminal fragment of 83 amino acids (C83). However, the potential molecular mechanism remains elusive.
Objective:
The aim of the present study was to investigate the effect of nicotine on AβPP processing in SH-SY5Y cells that stably express human Swedish mutant AβPP695 (SH-SY5Y-AβPP695).
Methods:
The expression of AβPP and its C-terminal fragments including C99, C89, and C83, was measured in SH-SY5Y-AβPP695 cells treated with nicotine for 6 h. Protein kinase C (PKC) antagonist Ro30-8220 or agonist PMA was used to determine the role of PKC in AβPP processing. Lentivirus-mediated shRNA targeting receptor for activated C-kinase 1 (RACK1) gene was added into the media to knockdown RACK1 expression, and then AβPP processing was examined.
Results:
The results showed that 6 h of nicotine exposure increased the expression of α-secretase (ADAM10) and C83 in a dose dependent manner. While the β-secretase (BACE1), AβPP amyloidogenic processing products C89 and C99 as well as Aβ peptides (including Aβ40 and Aβ42) remained unchanged. We also found that nicotine elevated the expression of phosphorylated PKC (P-PKC) and RACK1 on the cytomembrane. PKC antagonist Ro30-8220 treatment prevented the increase of ADAM10 and C83 by nicotine. Genetic knockdown RACK1 significantly inhibited P-PKC, and consequently abolished the increase of ADAM10 and C83 by nicotine.
Conclusion:
Taken together, these results indicate that nicotine effectively promotes AβPP nonamyloidogenic processing via RACK1-dependent activation of PKC in SH-SY5Y-AβPP695 cells and could be a potential molecule for AD treatment.
WangX, ZhouX, LiG, ZhangY, WuY, SongW (2017) Modifications and trafficking of APP in the pathogenesis of Alzheimer’s disease. Front Mol Neurosci10, 294.
6.
SisodiaSS (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A89, 6075–6079.
7.
CookDG, FormanMS, SungJC, LeightS, KolsonDL, IwatsuboT, LeeVM, DomsRW (1997) Alzheimer’s A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med3, 1021–1023.
8.
HartmannT, BiegerSC, BruhlB, TienariPJ, IdaN, AllsopD, RobertsGW, MastersCL, DottiCG, UnsickerK, BeyreutherK (1997) Distinct sites of intracellular production for Alzheimer’s disease A beta40/42 amyloid peptides. Nat Med3, 1016–1020.
9.
XuH, SweeneyD, WangR, ThinakaranG, LoAC, SisodiaSS, GreengardP, GandyS (1997) Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A94, 3748–3752.
10.
PatersonD, NordbergA (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol61, 75–111.
11.
Hellstrom-LindahlE, MousaviM, ZhangX, RavidR, NordbergA (1999) Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brainBrain Res Mol Brain Res66, 94–103.
12.
GuanZZ, ZhangX, RavidR, NordbergA (2000) Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer’s disease. J Neurochem74, 237–243.
AlkadhiKA (2018) Delayed effects of combined stress and Abeta infusion on L-LTP of the dentate gyrus: Prevention by nicotine. Neurosci Lett682, 10–15.
15.
HurstR, RollemaH, BertrandD (2013) Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacol Ther137, 22–54.
16.
UzumG, DilerAS, BahcekapiliN, TasyurekliM, ZiylanYZ (2004) Nicotine improves learning and memory in rats: Morphological evidence for acetylcholine involvement. Int J Neurosci114, 1163–1179.
17.
GonçalvesRGJ, VasquesJF, TrindadeP, SerfatyCA, Campello-CostaP, Faria-MelibeuAC (2016) Nicotine-induced plasticity in the retinocollicular pathway: Evidence for involvement of amyloid precursor protein. Neuroscience313, 1–9.
18.
MousaviM, Hellstrom-LindahlE (2009) Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro. Neurochem Int54, 237–244.
19.
GutalaR, WangJ, HwangYY, HaqR, LiMD (2006) Nicotine modulates expression of amyloid precursor protein and amyloid precursor-like protein 2 in mouse brain and in SH-SY5Y neuroblastoma cells. Brain Res1093, 12–19.
20.
KoideM, NishizawaS, YamamotoS, YamaguchiM, NambaH, TerakawaS (2005) Nicotine exposure, mimicked smoking, directly and indirectly enhanced protein kinase C activity in isolated canine basilar artery, resulting in enhancement of arterial contraction. J. Cereb Blood Flow Metab25, 292–301.
TuominenRK, McMillianMK, YeH, StachowiakMK, HudsonPM, HongJS (1992) Long-term activation of protein kinase C by nicotine in bovine adrenal chromaffin cells. J Neurochem58, 1652–1658.
23.
AlkonDL, SunMK, NelsonTJ (2007) PKC signaling deficits: A mechanistic hypothesis for the origins of Alzheimer’s disease. Trends Pharmacol Sci28, 51–60.
24.
PascaleA, FortinoI, GovoniS, TrabucchiM, WetselWC, BattainiF (1996) Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem67, 2471–2477.
25.
BattainiF, PascaleA, PaolettiR, GovoniS (1997) The role of anchoring protein RACK1 in PKC activation in the ageing rat brain. Trends Neurosci20, 410–415.
26.
BattainiF, PascaleA, LucchiL, PasinettiGM, GovoniS (1999) Protein kinase C anchoring deficit in postmortem brains of Alzheimer’s disease patients. Exp Neurol159, 559–564.
27.
NiH, RuiQ, XuY, ZhuJ, GaoF, DangB, LiD, GaoR, ChenG (2018) RACK1 upregulation induces neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats. Exp Neurol304, 102–113.
28.
ZhuJ, ChenX, SongY, ZhangY, ZhouL, WanL (2016) Deficit of RACK1 contributes to the spatial memory impairment via upregulating BECLIN1 to induce autophagy. Life Sci151, 115–121.
29.
ShimohamaS, KamiyaS, TaniguchiT, KimuraJ (1998) Intracellular receptors for activated C-kinase in the postmortem human brain: No alteration in Alzheimer disease. Alzheimer Dis Assoc Disord12, 384–386.
30.
DuY, DuY, ZhangY, HuangZ, FuM, LiJ, PangY, LeiP, WangYT, SongW, HeG, DongZ (2019) MKP-1 reduces Abeta generation and alleviates cognitive impairments in Alzheimer’s disease models. Signal Transduct Target Ther4, 58.
31.
MattsonMP (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev77, 1081–1132.
32.
TurnerPR, O’ConnorK, TateWP, AbrahamWC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol70, 1–32.
33.
FolR, BraudeauJ, LudewigS, AbelT, WeyerSW, RoedererJP, BrodF, AudrainM, BemelmansAP, BuchholzCJ, KorteM, CartierN, MüllerUC (2016) Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model. Acta Neuropathol131, 247–266.
34.
NewhousePA, KeltonM (2000) Nicotinic systems in central nervous systems disease: Degenerative disorders and beyond. Pharm Acta Helv74, 91–101.
35.
FujiiS, JiZ, MoritaN, SumikawaK (1999) Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res846, 137–143.
36.
YakelJL (2012) Nicotinic ACh receptors in the hippocampus: Role in excitability and plasticity. Nicotine Tob Res14, 1249–1257.
37.
LiuQ, ZhangJ, ZhuH, QinC, ChenQ, ZhaoB (2006) Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J21, 61–73.
38.
HassanM, ShahzadiS, RazaH, AbbasiMA, AlashwalH, ZakiN, MoustafaAA, SeoS-Y (2019) Computational investigation of mechanistic insights of Aβ42 interactions against extracellular domain of nAChRα7 in Alzheimer’s disease. Int J Neurosci129, 666–680.
39.
LiMD (2018) Nicotine modulates innate immune pathways via α7 nicotinic acetylcholine receptor. In Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment, Li MD, ed. Springer Singapore, Singapore, pp. 287-302.
40.
HanG, AnL, YangB, SiL, ZhangT (2014) Nicotine-induced impairments of spatial cognition and long-term potentiation in adolescent male rats. Hum Exp Toxicol33, 203–213.
41.
DengJ, ShenC, WangYJ, ZhangM, LiJ, XuZQ, GaoCY, FangCQ, ZhouHD (2010) Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats. Eur J Pharmacol637, 83–88.
ArispeN, PollardHB, RojasE (1994) beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Mol Cell Biochem140, 119–125.
44.
SandersonKL, ButlerL, IngramVM (1997) Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: Relation to Alzheimer’s disease. Brain Res744, 7–14.
45.
ZamaniMR, AllenYS (2001)Biol Psychiatry49, 221–232Nicotine and its interaction with beta-amyloid prote, A short review.
